1. Home
  2. QXL vs LONA Comparison

QXL vs LONA Comparison

Compare QXL & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quantum X Labs Inc. Common Stock

QXL

Quantum X Labs Inc. Common Stock

N/A

Current Price

$5.60

Market Cap

75.6M

Sector

Technology

ML Signal

N/A

Logo LeonaBio Inc. Common Stock

LONA

LeonaBio Inc. Common Stock

N/A

Current Price

$6.65

Market Cap

71.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QXL
LONA
Founded
N/A
2011
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
75.6M
71.2M
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
QXL
LONA
Price
$5.60
$6.65
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
62.4K
38.3K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$26,941,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$57.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.05
$4.21
52 Week High
$7.70
$14.21

Technical Indicators

Market Signals
Indicator
QXL
LONA
Relative Strength Index (RSI) 64.19 47.88
Support Level $4.09 $6.86
Resistance Level N/A $8.57
Average True Range (ATR) 0.35 0.66
MACD 0.13 -0.04
Stochastic Oscillator 74.87 37.79

Price Performance

Historical Comparison
QXL
LONA

About QXL Quantum X Labs Inc. Common Stock

Quantum X Labs Inc is an Israel-based multi-disciplinary quantum technology company focused on the research, development, and commercialization of quantum technologies and intellectual property. The company operates across a broad range of domains, including quantum computing, quantum sensing, navigation systems, atomic clocks, and quantum algorithms, with applications spanning defense, aerospace, transportation, cybersecurity, and life sciences.

About LONA LeonaBio Inc. Common Stock

LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a single operating segment, developing and commercializing therapeutics.

Share on Social Networks: